LYSM2_HUMAN - dbPTM
LYSM2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID LYSM2_HUMAN
UniProt AC Q8IV50
Protein Name LysM and putative peptidoglycan-binding domain-containing protein 2
Gene Name LYSMD2
Organism Homo sapiens (Human).
Sequence Length 215
Subcellular Localization
Protein Description
Protein Sequence MADSSPALSLREGGPRAPRPSAPSPPPRSRSGSESEEAELSLSLARTKTRSYGSTASVRAPLGAGVIERHVEHRVRAGDTLQGIALKYGVTMEQIKRANKLFTNDCIFLKKTLNIPVISEKPLLFNGLNSIDSPENETADNSFSQEEEPVVAGEDLPPPSPQESDVQPVQPEEVSARDFLQRLDLQIKLSTQAAKKLKEESRDEESPYATSLYHS
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MADSSPALS
------CCCCCCCCC
25.9522814378
4Phosphorylation----MADSSPALSLR
----CCCCCCCCCCC
28.7829255136
5Phosphorylation---MADSSPALSLRE
---CCCCCCCCCCCC
18.1023401153
9PhosphorylationADSSPALSLREGGPR
CCCCCCCCCCCCCCC
27.7322199227
21PhosphorylationGPRAPRPSAPSPPPR
CCCCCCCCCCCCCCC
54.8330266825
24PhosphorylationAPRPSAPSPPPRSRS
CCCCCCCCCCCCCCC
50.1629255136
29PhosphorylationAPSPPPRSRSGSESE
CCCCCCCCCCCCHHH
36.2529255136
31PhosphorylationSPPPRSRSGSESEEA
CCCCCCCCCCHHHHH
48.1730278072
33PhosphorylationPPRSRSGSESEEAEL
CCCCCCCCHHHHHHH
38.9130278072
35PhosphorylationRSRSGSESEEAELSL
CCCCCCHHHHHHHHH
42.2925159151
41PhosphorylationESEEAELSLSLARTK
HHHHHHHHHHHHHHC
13.8630301811
43PhosphorylationEEAELSLSLARTKTR
HHHHHHHHHHHHCCC
19.3330301811
49PhosphorylationLSLARTKTRSYGSTA
HHHHHHCCCCCCCCE
25.0027251275
51PhosphorylationLARTKTRSYGSTASV
HHHHCCCCCCCCEEE
38.7928555341
52PhosphorylationARTKTRSYGSTASVR
HHHCCCCCCCCEEEE
16.29-
54PhosphorylationTKTRSYGSTASVRAP
HCCCCCCCCEEEECC
16.7427251275
55PhosphorylationKTRSYGSTASVRAPL
CCCCCCCCEEEECCC
20.7029214152
57PhosphorylationRSYGSTASVRAPLGA
CCCCCCEEEECCCCC
16.5423401153
103PhosphorylationKRANKLFTNDCIFLK
HHHHHHCCCCEEEEE
40.3525599653
110UbiquitinationTNDCIFLKKTLNIPV
CCCEEEEECCCCCCC
32.72-
110AcetylationTNDCIFLKKTLNIPV
CCCEEEEECCCCCCC
32.7227452117
195AcetylationKLSTQAAKKLKEESR
HHHHHHHHHHHHHHC
62.7525953088
201PhosphorylationAKKLKEESRDEESPY
HHHHHHHHCCCCCCC
46.2322199227
206PhosphorylationEESRDEESPYATSLY
HHHCCCCCCCHHHCC
22.5928796482
208PhosphorylationSRDEESPYATSLYHS
HCCCCCCCHHHCCCC
31.6125159151
210PhosphorylationDEESPYATSLYHS--
CCCCCCHHHCCCC--
17.2728796482
211PhosphorylationEESPYATSLYHS---
CCCCCHHHCCCC---
20.8228796482
213PhosphorylationSPYATSLYHS-----
CCCHHHCCCC-----
10.3628796482
215PhosphorylationYATSLYHS-------
CHHHCCCC-------
28.4928796482

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of LYSM2_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of LYSM2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of LYSM2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions

Oops, there are no PPI records of LYSM2_HUMAN !!

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of LYSM2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-33, AND MASSSPECTROMETRY.
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells.";
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.;
Nat. Biotechnol. 23:94-101(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-208 AND TYR-213, ANDMASS SPECTROMETRY.

TOP